B-LYMPHOTROPIC PAPOVAVIRUS AND POSSIBILITY OF INFECTIONS IN HUMANS
B-LYMPHOTROPIC PAPOVAVIRUS AND POSSIBILITY OF INFECTIONS IN HUMANS
复制标题
DOI:
10.1002/jmv.1890060405
复制
发表时间:
1980-01-01
影响因子:
12.7
通讯作者:
HAUSEN, HZ
中科院分区:
文献类型:
--
作者:
BRADE, L;MULLERLANTZSCH, N;HAUSEN, HZ
A novel member of the papovavirus group was isolated from EBV[Epstein-Barr virus)-transformed African green monkey (AGM) B-lymphoblasts. The virus is characterized by its B-lymphotropic host range and was tentatively named lymphotropic papovavirus (LPV). Seroepidemiological studies revealed that, besides sera from AGM, a substantial proportion of human sera reacted with antigens of this virus. The specificity of this reaction observed in indirect immunofluorescence tests was underlined by immunoprecipitation (IP) and neutralization studies. IP demonstrated that AGM and human sera reacting in immunofluorescence with LPV antigens precipitated polypeptides of .apprx. 40 kilodaltons. Those polypeptides were detected only in LPV-infected cultures. Sera of high reactivity in immunofluorescence tests also neutralize viral infectivity. Thus, an agent antigenetically closely related to AGM-LPV may infect part of the human population. The age distribution of the human antibody response revealed that a low percentage of sera reacted in age groups < 30 yr. Thereafter, .apprx. 30% of all sera exhibited antibodies to LPV antigens. There was a slight increase in seroreactivity in sera from patients tested for infectious hepatitis when compared to non-selected human sera.